Filter
1276
Filtered Results: 1276
Text search:
molecular
testing
Featured
Recommendations
168
New Publications
271
Language
Document type
No document type
612
Guidelines
265
Studies & Reports
220
Manuals
68
Strategic & Response Plan
56
Fact sheets
27
Training Material
14
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
80
Western and Central Europe
44
Global
40
Latin America and the Carribbean
33
Africa
29
Kenya
28
Eastern Europe
24
Tanzania
23
South Africa
22
Ethiopia
20
Brazil
18
Germany
17
Nigeria
14
West and Central Africa
14
East and Southern Africa
14
Sierra Leone
13
Malawi
12
Rwanda
11
South–East Asia Region
11
Uganda
11
Russia
11
Philippines
10
Colombia
9
Peru
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Zimbabwe
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
Senegal
5
USA
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Burkina Faso
4
Ecuador
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Pakistan
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
North America
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
126
Policies & Guidelines HIV & TB
99
COVID-19
86
Studies & Reports
73
Policies
44
TB
44
Drugs & Medical Equipment
35
Disease Prevention & Control
26
Women & Child Health
22
Capacity Building
20
Virology
18
Pediatrics
17
Malaria
17
General Guidelines
12
Statistics
12
Non-communicable Diseases
12
HIV & STI
12
Bacteriology
11
Communicable Diseases
10
Hepatitis
10
Vaccine-preventable Diseases
10
Countries
10
Parasitology
9
Paediatrics
8
NTDs & Others
8
Yellow Fever
7
Vector Control
6
Dengue
6
Cancer
5
Monitoring & Evaluation
5
MPOX - Monkeypox
5
Rabies
4
Diabetes
4
Cancer Treatment & Resources
4
Infection Control & Prevention (IPC)
4
Snakebites
4
Chagas
4
Hemorrhagic Fever
4
Diarrhoeal Disease/Cholera
4
Medical Devices & Equipment
4
Community Health
4
Quality Control & Assurance
4
Leishmaniasis
4
Water
4
Public Health
3
Yaws
3
Cervical Cancer
3
Breast Cancer
3
Public Health
3
NCD
3
Cardiovascular Diseases
3
Clinical Guidelines
3
Demograhic Health Surveys DHS
3
Humanitarian Crisis
3
Immunization
3
Surgery & Anaesthesia
3
General Guidelines
3
Communicable Diseases
3
Gynaecology & Obstetrics
3
Health Systems
3
Women & Child Health
3
Maternal Health
3
Laboratory Quality Assurance
3
Reproductive Health
3
Zika
2
Pharmacy & Technology
2
Hand Hygiene
2
Community Health
2
Yersinia pestis (Plague)
2
Information, Education and Communication (IEC)
2
Other
2
Respiratory Infections
2
Needs Assessment
2
Key Resources
2
Food Security & Nutrition
2
Dental & Eye Care
1
Child Health
1
Buruli Ulcer
1
Disaster Preparedness
1
Schistosomiasis
1
Other Cancer diseases
1
Palliative Care
1
Mental Health
1
COPD/Asthma
1
Leprosy
1
Protection & Security
1
Laboratory Technologies
1
Age & Elderly
1
Radiology and Diagnostic
1
Toolboxes
Country specific documents
48
Diagnostics & Laboratory Guidance
45
Detection & Diagnosis
43
Country specific
36
Clinical Guidelines
32
Prevention & Control
30
Drug resistant TB
27
Adults
20
TB/HIV Coinfection
17
Surveillance & Contact tracing
16
TB & Prisoners
15
Children/Adolescents Mental Disorders
14
Surveillance
13
International
12
Reports & Studies
12
Public Health
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
11
Children
11
Reports
11
Prevention & Preparedness
11
Testing Guidelines
11
HIV testing & services
10
Children & Adolescents
10
Laboratory
10
Studies
10
General
10
Infection Control General
10
Essential Medicines & Devices Lists
10
Eastern Europe & Central Asia
10
SEAR (South-east Asia Region)
10
Surveillance
9
Influenza Prevention & Control
9
General
9
Laboratory
9
Genomic sequencing
9
Disease Prevention & Control
9
Research & Access
9
Clinical Aspects, Treatment & Prevention
8
TB & Other Vulnerable Populations
8
Context & Facts, Travel Advice
8
Essential Medicines & Medical Devices
8
Eastern Europe and central Asia
8
Policies & Strategies
7
Childhood TB
7
Laboratory Guidance
7
Agriculture & Veterinary
7
Clinical Aspects
7
Research
7
Global Impact: Socio-economic, health services, TB & HIV
7
SARS-CoV-2 Variants
7
General documents One Health
7
Clinical Aspects & Diagnostics
7
TB
7
Treatment & Prevention
6
Opportunistic Infections
6
Laboratory & Sampling
6
Treatment Guidelines
6
TB/COVID-19
6
Advocacy & Communication
6
Clinical Aspects & Diagnostics
6
Overview, Studies & Reports
6
Policies and guidelines
6
Training
6
Germany
6
Assessment & Studies
5
ART Drug Resistance
5
IPC
5
Ebola Prevention & Control
5
Vaccines & Immunization
5
Yellow Fever Prevention & Control
5
Clinical Guidelines
5
Country Specific
5
Appeals and Response Plans
5
Hospital Readiness/Essential Health Services
5
Long COVID/ Post-COVID Syndrome
5
Colombia
5
Essential Medicines
5
Falsified & Substandard
5
Zoonoses
5
MPOX - Monkeypox
5
Studies & Reports
5
Access to treatment and laboratory
5
General
5
Neurological Disorders
5
Assessment
5
Clinical Guidelines
5
Antiretroviral Treatment ART
5
Kenya
5
Preparedness & Prevention
5
Outbreak Prevention & Control
4
Influenza
4
Surveillance
4
HIV
4
TB
4
Ethiopia
4
Context & Facts
4
For Health Worker
4
Paediatrics
4
Access & Strategy
4
Rational use of Medicine
4
MPOX - Monkeypox
4
Chagas
4
Clinical Aspects & Diagnostics
4
Studies & Reports
4
Studies & Reports
4
Dengue Prevention & Control
4
Latin America & the Carribean
4
HIV and coinfection
4
Chikungunya Prevention & Control
4
AmR (Region of Americas)
4
Gynaecology / Obstetrics
3
Meningitis Prevention & Control
3
Moldova
3
Azerbaijan
3
Yellow Fever
3
Preparedness, Response & Risk Communication
3
Hepatitis
3
Treatment Guidelines HIV
3
Namibia
3
Stroke
3
Vaccination
3
Georgia
3
Drug resistance
3
Russia
3
Supporting tools
3
Infection Prevention & Hygiene
3
Clinical Aspects
3
Public Health
3
For Pregnant Women
3
Training, others
3
Scientific & Research Studies
3
Gender Aspects
3
Oxygen Therapy
3
Non-pharmaceutical interventions (NPIs)
3
TB/HIV
3
Quality Assurance
3
Traditional & Herbal Medicines
3
HIV &TB
3
Antimicrobial Resistance (AMR)
3
Clinical Aspects & Diagnostics
3
Studies & Reports
3
Studies & Reports
3
Yaws & other Endemic Treponematoses
3
Studies & Reports
3
General
3
Tuberculosis
3
Nigeria
3
Zika Prevention & Control
3
Western & Central Europe
3
Preparedness & Prevention
3
Laboratory & Diagnostics
3
Public Health
3
Neurological disorders, Others
3
Biosafety
2
Clinical Guidelines
2
Chemical Attacks
2
Policies & Strategies
2
Hand Hygiene
2
Vector Control
2
Ukraine
2
South Africa
2
WPRO (Western Pacific Region)
2
Prevention Guidelines
2
Measures ICF/ Model Disability Survey
2
Eastern Mediterranean Region
2
National Policies
2
Communication & Training
2
Drug resistance
2
Tools for Rational use
2
Prophylaxis
2
Preparedness, Response & Risk Communication
2
Standard Precautions
2
Clinical aspects
2
Attention deficit hyperactivity disorder (ADHD)
2
Country Guidelines
2
Health Personnel
2
Essential List
2
Prison & Detention
2
For Older People
2
Educational Settings
2
Physical Distancing
2
Situation Reports COVID-19
2
Vaccine Candidates & Research
2
Immunization Guidelines
2
Long-term Care Facilities
2
Preparedness, Response & Risk Communication
2
Logistics & Supply
2
COVAX Initiative
2
Vaxzevria (Astra Zeneca)
2
Overview
2
Biodiversity shift
2
Climate Change General
2
Agriculture
2
Pharmacy Practice
2
One Health
2
Argentina
2
General Guidelines for Rational Use
2
Pharmacovigilance
2
Health Care Systems
2
Prevention & Measures
2
Infectious Diseases
2
MPOX -Monkeybox Prevention & Control
2
Leishmaniasis
2
Statistics & Facts
2
Statistics & Facts
2
Leptospirosis
2
Snakebite envenoming
2
General Information & Methodology
2
Health Financing Toolbox
2
Clinical Aspects & Diagnosis
2
Women
2
Prevention & Strategies
2
Clinical Guidelines
2
Co-Morbidities (except TB)
2
Autism
2
Technical Information
2
Substance Use Disorders & Addiction
2
Malawi
2
TB/HIV Global
2
Education of students & professionals
2
Nutrition
2
Prevention of mother-to-child transmission (PMTCT)
2
Uganda
2
Paediatrics
2
Infection Control
2
Context & Facts
2
HIV in Key Populations
2
Action Plans, Policies & Response
2
Public Health
2
Plague Prevention & Control
2
War & Conflict
1
Drugs
1
Rapid Response
1
Natural Disaster
1
Health Systems
1
Treatment Guidelines
1
Psychosocial Support (MHPSS)
1
Behaviour Change/Life Skill Education
1
Intellectual Disability
1
General Reports
1
TB & Drug Abuse
1
Children with Disabilities
1
Posttraumatic stress disorder Adults
1
Training
1
Guillain-Barré Syndrome
1
HIV surveillance
1
Pediatrics
1
Zambia
1
Plague
1
Neuropsychology of Trauma
1
Training Manuals
1
Substance Use Disorders, Others
1
Context, Facts & Travel Advice
1
Children
1
Social Mobilisation
1
Dengue
1
Policies
1
Infection Control
1
Platforms and initiatives
1
General Mental Health Guidelines
1
Eastern Europe
1
General Studies & Reports
1
Cholera Prevention & Control
1
Global
1
Training Material
1
People who injecting Drugs
1
Rwanda
1
SOPs
1
African Region
1
Mozambique
1
Ebola
1
Public Health
1
Child Health / Pediatrics
1
Microcephaly
1
Training
1
Workplace
1
Manual & Leaflet
1
Belarus
1
HIV / AIDS
1
Medical professionals
1
Sustainable Development Goals
1
Sex Worker
1
Clinical Guidelines
1
Cannabis
1
Situation Reports & Updates
1
Best Practice
1
Hand Hygiene
1
PPE Personel Protective Equipment
1
Covid-19 & the One Health Approach
1
COVID-19
1
For Parents & Children
1
For Migrants & Refugees
1
Simulations
1
Sustainability
1
Child Protection
1
HIV and COVID-19
1
Infection Control & Prevention (IPC)
1
Blood Supply
1
Latin America
1
Community Health
1
Environmental NPIs
1
Ebola Treatment Center
1
Psychosocial Support
1
Fair Allocation & Ethical Aspects
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Research & Pipeline
1
Hand Hygiene
1
Studies & Reports
1
Palliative Care
1
Estonia
1
Latin America
1
Peru
1
Booster Doses
1
Ecuador
1
Planetary Health
1
Reports
1
Food environments
1
Overview & reports
1
Mobility
1
Model Formulary
1
Cancer
1
Intensive Care Unit
1
Guiding documents and principles
1
Agriculture incl. animal husbandry
1
Waste Managment
1
Public Health
1
Non-communicable Diseases NCD
1
WASH Water Sanitation & Hygiene
1
Water Pollution
1
Health Impact & Climate Change
1
Nuclear & Chemical Hazards
1
Health Care In Conflict Settings
1
Dengue & Chikungunya
1
Strategies & Roadmaps
1
Capacity Building & Resources
1
Information & Education Material (IEC)
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Echinocccosis
1
Onchocerciasis
1
Taeniasis/Cysticercosis
1
Education
1
General Information
1
Prevention & Strategies
1
Statistics & Facts
1
Studies & Reports
1
Armenia
1
Clinical Aspects & Diagnosis
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Romania
1
Asia and Pacific
1
General
1
others
1
Alzheimer's Disease & Dementia
1
Ghana
1
General Aspects
1
Bipolar Affective Disorders
1
Regional Reports & Guidelines, others
1
One Health
1
Policy
1
Asia
1
Prophylactic Treatment
1
Diarrhoea
1
AR (African Region)
1
Technical Information
1
Technical Information
1
Reproductive Health
1
Vision Loss & Blindness
1
Clinical Guidelines
1
International
1
Situation Reports
1
Travel Medicine
1
Others
1
Tajikistan
1
HIV service delivery
1
Kazakhstan
1
MHPSS Guidelines
1
Learning Disabilities
1
South-east Asia Region
1
Laboratory
1
Marburg Virus Situation Reports
1
Epidemiology
1
Chikungunya
1
Case Definitions
1
Situation Reports, others
1
Key Resources
1
AMR
1
Meningitis & Encephalitis
1
Situation Reports & Updates
1
Treatment & Clinical Management
1
To understand the national situation, Ethiopia did a situation assessment, launched its first strategy in 2011, and took action to contain AMR, as detailed in the blue boxes found throughout this strategy. This updated version of the strategy was in response to the revised health and medicines polic...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi...
Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnosis for co-infection can be detected simultaneously using th...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
In response to the recent publication “Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes” by Dadzie et al., it is important to clarify and highlight the positive and unequivocal research and operational contributio...
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the
South of the United States. It is an important cause of early mortality and morbidity, and it is associated with poverty and stigma. A third of
the cases evolve into chronic...
Since 2000, concerted efforts by national programmes, supported by public–private partnerships, nongovernmental organizations, donors and academia under the auspices and coordination of the World Health Organization (WHO), have produced important achievements in the control of human African trypan...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
The development of this target product profile (TPP) was led by the WHO Department of Control of Ne-
glected Tropical Diseases (NTD) following standard WHO guidance for TPP development. In order to
identify and prioritize diagnostic needs, a WHO NTD Diagnostics Technical Advisory Group (DTAG)
was...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
